SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Mellors J.W., Rinaldo C.R. Jr., Gupta P., White R.M., Todd J.A., Kingsley L.A. (1996) Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science (New York, NY) 272: 116770.
  • 2
    Egger M., May M., Chene G., Phillips A.N., Ledergerber B., Dabis F., Costagliola D., D’arminio Monforte A., De Wolf F., Reiss P., Lundgren J.D., Justice A.C., Staszewski S., Leport C., Hogg R.S., Sabin C.A., Gill M.J., Salzberger B., Sterne J.A. (2002) Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 360: 11929.
  • 3
    Telenti A., Goldstein D.B. (2006) Genomics meets HIV-1. Nat Rev 4: 86573.
  • 4
    Simon V., Ho D.D., Abdool Karim Q. (2006) HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet 368: 489504.
  • 5
    Deeks S.G., Walker B.D. (2007) Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 27: 40616.
  • 6
    Carrington M., O’brien S.J. (2003) The influence of HLA genotype on AIDS. Annu Rev Med 54: 53551.
  • 7
    O’brien S.J., Gao X., Carrington M. (2001) HLA and AIDS: a cautionary tale. Trends Mol Med 7: 37981.
  • 8
    Goulder P.J., Watkins D.I. (2008) Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 8: 61930.
  • 9
    Stephens H.A. (2005) HIV-1 diversity versus HLA class I polymorphism. Trends Immunol 26: 417.
  • 10
    Migueles S.A., Sabbaghian M.S., Shupert W.L., Bettinotti M.P., Marincola F.M., Martino L., Hallahan C.W., Selig S.M., Schwartz D., Sullivan J., Connors M. (2000) HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci U S A 97: 270914.
  • 11
    Kaslow R.A., Carrington M., Apple R., Park L., Munoz A., Saah A.J., Goedert J.J., Winkler C., O’brien S.J., Rinaldo C., Detels R., Blattner W., Phair J., Erlich H., Mann D.L. (1996) Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 2: 40511.
  • 12
    Kiepiela P., Leslie A.J., Honeyborne I., Ramduth D., Thobakgale C., Chetty S., Rathnavalu P., Moore C., Pfafferott K.J., Hilton L., Zimbwa P., Moore S., Allen T., Brander C., Addo M.M., Altfeld M., James I., Mallal S., Bunce M., Barber L.D., Szinger J., Day C., Klenerman P., Mullins J., Korber B., Coovadia H.M., Walker B.D., Goulder P.J. (2004) Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432: 76975.
  • 13
    Carrington M., Nelson G.W., Martin M.P., Kissner T., Vlahov D., Goedert J.J., Kaslow R., Buchbinder S., Hoots K., O’brien S.J. (1999) HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science (New York, NY) 283: 174852.
  • 14
    Gao X., Nelson G.W., Karacki P., Martin M.P., Phair J., Kaslow R., Goedert J.J., Buchbinder S., Hoots K., Vlahov D., O’brien S.J., Carrington M. (2001) Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 344: 166875.
  • 15
    Unaids (2008) Status of the global HIV epidemic. 2008 Report on the global AIDS epidemic.
  • 16
    Furutsuki T., Hosoya N., Kawana-Tachikawa A., Tomizawa M., Odawara T., Goto M., Kitamura Y., Nakamura T., Kelleher A.D., Cooper D.A., Iwamoto A. (2004) Frequent transmission of cytotoxic-T-lymphocyte escape mutants of human immunodeficiency virus type 1 in the highly HLA-A24-positive Japanese population. J Virol 78: 843745.
  • 17
    Kawashima Y., Pfafferott K., Frater J., Matthews P., Payne R., Addo M., Gatanaga H., Fujiwara M., Hachiya A., Koizumi H., Kuse N., Oka S., Duda A., Prendergast A., Crawford H., Leslie A., Brumme Z., Brumme C., Allen T., Brander C., Kaslow R., Tang J., Hunter E., Allen S., Mulenga J., Branch S., Roach T., John M., Mallal S., Ogwu A., Shapiro R., Prado J.G., Fidler S., Weber J., Pybus O.G., Klenerman P., Ndung’u T., Phillips R., Heckerman D., Harrigan P.R., Walker B.D., Takiguchi M., Goulder P. (2009) Adaptation of HIV-1 to human leukocyte antigen class I. Nature.
  • 18
    Itoh Y., Mizuki N., Shimada T., Azuma F., Itakura M., Kashiwase K., Kikkawa E., Kulski J.K., Satake M., Inoko H. (2005) High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics 57: 71729.
  • 19
    Ogata S., Shi L., Matsushita M., Yu L., Huang X.Q., Shi L., Sun H., Ohashi J., Muramatsu M., Tokunaga K., Chu J.Y. (2007) Polymorphisms of human leucocyte antigen genes in Maonan people in China. Tissue Antigens 69: 15460.
  • 20
    Storey J.D., Tibshirani R. (2003) Statistical significance for genome wide studies. Proc Natl Acad Sci U S A 100: 94405.
  • 21
    Cao K., Hollenbach J., Shi X., Shi W., Chopek M., Fernandez-Vina M.A. (2001) Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. Hum Immunol 62: 100930.
  • 22
    Pereyra F., Addo M.M., Kaufmann D.E., Liu Y., Miura T., Rathod A., Baker B., Trocha A., Rosenberg R., Mackey E., Ueda P., Lu Z., Cohen D., Wrin T., Petropoulos C.J., Rosenberg E.S., Walker B.D. (2008) Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J Infect Diseases 197: 56371.
  • 23
    Sette A., Sidney J. (1999) Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50: 20112.
  • 24
    Trachtenberg E., Korber B., Sollars C., Kepler T.B., Hraber P.T., Hayes E., Funkhouser R., Fugate M., Theiler J., Hsu Y.S., Kunstman K., Wu S., Phair J., Erlich H., Wolinsky S. (2003) Advantage of rare HLA supertype in HIV disease progression. Nat Med 9: 92835.
  • 25
    Carrington M., Martin M.P., Van Bergen J. (2008) KIR-HLA intercourse in HIV disease. Trends Microbiol 16: 6207.
  • 26
    Alter G., Altfeld M. (2009) NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection. J Intern Med 265: 2942.
  • 27
    Flores-Villanueva P.O., Yunis E.J., Delgado J.C., Vittinghoff E., Buchbinder S., Leung J.Y., Uglialoro A.M., Clavijo O.P., Rosenberg E.S., Kalams S.A., Braun J.D., Boswell S.L., Walker B.D., Goldfeld A.E. (2001) Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc Natl Acad Sci U S A 98: 51405.
  • 28
    Martin M.P., Gao X., Lee J.H., Nelson G.W., Detels R., Goedert J.J., Buchbinder S., Hoots K., Vlahov D., Trowsdale J., Wilson M., O’brien S.J., Carrington M. (2002) Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 31: 42934.
  • 29
    Altfeld M., Allen T.M., Kalife E.T., Frahm N., Addo M.M., Mothe B.R., Rathod A., Reyor L.L., Harlow J., Yu X.G., Perkins B., Robinson L.K., Sidney J., Alter G., Lichterfeld M., Sette A., Rosenberg E.S., Goulder P.J., Brander C., Walker B.D. (2005) The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design. J Virol 79: 50005.
  • 30
    Goulder P.J., Brander C., Tang Y., Tremblay C., Colbert R.A., Addo M.M., Rosenberg E.S., Nguyen T., Allen R., Trocha A., Altfeld M., He S., Bunce M., Funkhouser R., Pelton S.I., Burchett S.K., Mcintosh K., Korber B.T., Walker B.D. (2001) Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 412: 3348.
  • 31
    Goulder P.J., Phillips R.E., Colbert R.A., Mcadam S., Ogg G., Nowak M.A., Giangrande P., Luzzi G., Morgan B., Edwards A., Mcmichael A.J., Rowland-Jones S. (1997) Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 3: 2127.
  • 32
    Streeck H., Lichterfeld M., Alter G., Meier A., Teigen N., Yassine-Diab B., Sidhu H.K., Little S., Kelleher A., Routy J.P., Rosenberg E.S., Sekaly R.P., Walker B.D., Altfeld M. (2007) Recognition of a defined region within p24 Gag by CD8+ T cells during primary human immunodeficiency virus type 1 infection in individuals expressing protective HLA class I alleles. J Virol 81: 772531.
  • 33
    Altfeld M., Kalife E.T., Qi Y., Streeck H., Lichterfeld M., Johnston M.N., Burgett N., Swartz M.E., Yang A., Alter G., Yu X.G., Meier A., Rockstroh J.K., Allen T.M., Jessen H., Rosenberg E.S., Carrington M., Walker B.D. (2006) HLA alleles associated with delayed progression to AIDS contribute strongly to the initial CD8(+) T Cell response against HIV-1. PLoS Med 3: e403.
  • 34
    Altfeld M., Addo M.M., Rosenberg E.S., Hecht F.M., Lee P.K., Vogel M., Yu X.G., Draenert R., Johnston M.N., Strick D., Allen T.M., Feeney M.E., Kahn J.O., Sekaly R.P., Levy J.A., Rockstroh J.K., Goulder P.J., Walker B.D. (2003) Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS (London, England) 17: 258191.
  • 35
    Leslie A.J., Pfafferott K.J., Chetty P., Draenert R., Addo M.M., Feeney M., Tang Y., Holmes E.C., Allen T., Prado J.G., Altfeld M., Brander C., Dixon C., Ramduth D., Jeena P., Thomas S.A., St John A., Roach T.A., Kupfer B., Luzzi G., Edwards A., Taylor G., Lyall H., Tudor-Williams G., Novelli V., Martinez-Picado J., Kiepiela P., Walker B.D., Goulder P.J. (2004) HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 10: 2829.
  • 36
    Kiepiela P., Ngumbela K., Thobakgale C., Ramduth D., Honeyborne I., Moodley E., Reddy S., De Pierres C., Mncube Z., Mkhwanazi N., Bishop K., Van Der Stok M., Nair K., Khan N., Crawford H., Payne R., Leslie A., Prado J., Prendergast A., Frater J., Mccarthy N., Brander C., Learn G.H., Nickle D., Rousseau C., Coovadia H., Mullins J.I., Heckerman D., Walker B.D., Goulder P. (2007) CD8 +T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 13: 4653.
  • 37
    Borghans J.A., Molgaard A., De Boer R.J., Kesmir C. (2007) HLA alleles associated with slow progression to AIDS truly prefer to present HIV-1 p24. PLoS ONE 2: e920.
  • 38
    Brumme Z.L., Tao I., Szeto S., Brumme C.J., Carlson J.M., Chan D., Kadie C., Frahm N., Brander C., Walker B., Heckerman D., Harrigan P.R. (2008) Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection. AIDS (London, England) 22: 127786.
  • 39
    Geldmacher C., Currier J.R., Herrmann E., Haule A., Kuta E., Mccutchan F., Njovu L., Geis S., Hoffmann O., Maboko L., Williamson C., Birx D., Meyerhans A., Cox J., Hoelscher M. (2007) CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients. J Virol 81: 24408.
  • 40
    Honeyborne I., Prendergast A., Pereyra F., Leslie A., Crawford H., Payne R., Reddy S., Bishop K., Moodley E., Nair K., Van Der Stok M., Mccarthy N., Rousseau C.M., Addo M., Mullins J.I., Brander C., Kiepiela P., Walker B.D., Goulder P.J. (2007) Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopes. J Virol 81: 366772.
  • 41
    Miura T., Brockman M.A., Schneidewind A., Lobritz M., Pereyra F., Rathod A., Block B.L., Brumme Z.L., Brumme C.J., Baker B., Rothchild A.C., Li B., Trocha A., Cutrell E., Frahm N., Brander C., Toth I., Arts E.J., Allen T.M., Walker B.D. (2009) HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte recognition. J Virol 83: 274355.
  • 42
    Goepfert P.A., Lumm W., Farmer P., Matthews P., Prendergast A., Carlson J.M., Derdeyn C.A., Tang J., Kaslow R.A., Bansal A., Yusim K., Heckerman D., Mulenga J., Allen S., Goulder P.J., Hunter E. (2008) Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. J Exp Med 205: 100917.
  • 43
    Chopera D.R., Woodman Z., Mlisana K., Mlotshwa M., Martin D.P., Seoighe C., Treurnicht F., De Rosa D.A., Hide W., Karim S.A., Gray C.M., Williamson C. (2008) Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage. PLoS Pathog 4: e1000033.
  • 44
    Martinez-Picado J., Prado J.G., Fry E.E., Pfafferott K., Leslie A., Chetty S., Thobakgale C., Honeyborne I., Crawford H., Matthews P., Pillay T., Rousseau C., Mullins J.I., Brander C., Walker B.D., Stuart D.I., Kiepiela P., Goulder P. (2006) Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J Virol 80: 361723.
  • 45
    Schneidewind A., Brockman M.A., Yang R., Adam R.I., Li B., Le Gall S., Rinaldo C.R., Craggs S.L., Allgaier R.L., Power K.A., Kuntzen T., Tung C.S., Labute M.X., Mueller S.M., Harrer T., Mcmichael A.J., Goulder P.J., Aiken C., Brander C., Kelleher A.D., Allen T.M. (2007) Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J Virol 81: 1238293.
  • 46
    Brockman M.A., Schneidewind A., Lahaie M., Schmidt A., Miura T., Desouza I., Ryvkin F., Derdeyn C.A., Allen S., Hunter E., Mulenga J., Goepfert P.A., Walker B.D., Allen T.M. (2007) Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. J. Virol 81: 1260818.
  • 47
    Crum-Cianflone N., Eberly L., Zhang Y., Ganesan A., Weintrob A., Marconi V., Barthel R.V., Fraser S., Agan B.K., Wegner S. (2009) Is HIV becoming more virulent? Initial CD4 cell counts among HIV seroconverters during the course of the HIV epidemic: 1985–2007. Clin Infect Dis.